BioSpace News Archive

International medical imaging IT and cybersecurity company Sectra has received an order from Institut Bergonié for its digital pathology solution.

Vera Therapeutics, Inc., a clinical-stage biotechnology company focused on developing treatments for immunological and inflammatory diseases, announced its launch backed by $80 million Series C financing led by Abingworth LLP.

Cue Health Inc. announced that its molecular, point-of-care COVID-19 Tests are being distributed to five additional states, including Colorado, Minnesota, Pennsylvania, Rhode Island and Utah, as part of the joint $481 million program with the U.S. Department of Health and Human Services and the Department of Defense.

Gritstone Oncology, Inc., a clinical-stage biotechnology company developing the next generation of cancer and infectious disease immunotherapies, announced that it is advancing development of a second generation vaccine against SARS-CoV-2, the virus that causes COVID-19, with potential for both prolonged protection and potency against Spike mutants.

Yesse Technologies, Inc., a New York-headquartered biotechnology company, developing a technology platform to digitize the sense of smell, announces that it was awarded a $670,000 grant from The Michael J. Fox Foundation for Parkinson’s Research.

DiNAQOR, a gene therapy platform company, announced that it has acquired EHT Technologies GmbH, a Germany-based engineered heart tissue technology platform company.

Combines Neurogene’s Manufacturing and Drug Development Capabilities with Edinburgh’s Novel Platform and Neurodevelopmental Disease Expertise

Metacrine, Inc. (Nasdaq: MTCR), a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients with liver and gastrointestinal diseases, today announced that the U.S. Food & Drug Administration (FDA) has granted Fast Track designation to MET642, the company’s second farnesoid X receptor (FXR) agonist, for the treatment of non-alcoholic steatohepatitis (NASH).

Teleflex Incorporated (NYSE: TFX) continues to deliver COMPLETE confidence with the release of the Arrow® ErgoPack® Complete Multi-Lumen Access Catheter (MAC) System and the Arrow® ErgoPack® Complete Percutaneous Sheath Introducer (PSI) System.

Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine, announced positive results from a study using MI GPSai™ an artificial intelligence driven product using DNA sequencing and whole transcriptome data to aid in the diagnosis of cancer.